169 related articles for article (PubMed ID: 33913092)
1. Efficacy of Zinc Acetate Treatment for Patients with Decompensated Liver Cirrhosis Complicated by Hypozincemia.
Horiguchi S; Naganuma A; Tateyama Y; Suzuki Y; Hoshino T; Saito N; Hatanaka T; Takakusagi S; Kosone T; Takagi H; Uraoka T; Kakizaki S
Biol Trace Elem Res; 2022 Feb; 200(2):497-504. PubMed ID: 33913092
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of treatment with zinc acetate hydrate in patients with liver cirrhosis complicated by zinc deficiency.
Ozeki I; Nakajima T; Suii H; Tatsumi R; Yamaguchi M; Arakawa T; Kuwata Y; Toyota J; Karino Y
Hepatol Res; 2020 Apr; 50(4):488-501. PubMed ID: 31729098
[TBL] [Abstract][Full Text] [Related]
3. Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection.
El-Sherif O; Jiang ZG; Tapper EB; Huang KC; Zhong A; Osinusi A; Charlton M; Manns M; Afdhal NH; Mukamal K; McHutchison J; Brainard DM; Terrault N; Curry MP
Gastroenterology; 2018 Jun; 154(8):2111-2121.e8. PubMed ID: 29535028
[TBL] [Abstract][Full Text] [Related]
4. Albumin-bilirubin score for predicting the in-hospital mortality of acute upper gastrointestinal bleeding in liver cirrhosis: A retrospective study.
Zou D; Qi X; Zhu C; Ning Z; Hou F; Zhao J; Peng Y; Li J; Deng H; Guo X
Turk J Gastroenterol; 2016 Mar; 27(2):180-6. PubMed ID: 27015623
[TBL] [Abstract][Full Text] [Related]
5. DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort.
Verna EC; Morelli G; Terrault NA; Lok AS; Lim JK; Di Bisceglie AM; Zeuzem S; Landis CS; Kwo P; Hassan M; Manns MP; Vainorius M; Akushevich L; Nelson DR; Fried MW; Reddy KR
J Hepatol; 2020 Sep; 73(3):540-548. PubMed ID: 32243960
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of creatinine-modified Child Pugh score for predicting short-term prognosis of patients with decompensated cirrhosis of liver as compare to original child Pugh score.
Samiullah S; Qasim R; Khalid S; Hussain BG; Mukhtair J; Akbar Y
J Ayub Med Coll Abbottabad; 2009; 21(2):64-7. PubMed ID: 20524472
[TBL] [Abstract][Full Text] [Related]
7. MELD vs Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis.
Papatheodoridis GV; Cholongitas E; Dimitriadou E; Touloumi G; Sevastianos V; Archimandritis AJ
World J Gastroenterol; 2005 May; 11(20):3099-104. PubMed ID: 15918197
[TBL] [Abstract][Full Text] [Related]
8. Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis.
Chen PC; Chen BH; Huang CH; Jeng WJ; Hsieh YC; Teng W; Chen YC; Ho YP; Sheen IS; Lin CY
Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1256-1263. PubMed ID: 31498284
[TBL] [Abstract][Full Text] [Related]
9. The Significance of Zinc in Patients with Chronic Liver Disease.
Nishikawa H; Asai A; Fukunishi S
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432541
[TBL] [Abstract][Full Text] [Related]
10. The model for the end-stage liver disease and Child-Pugh score in predicting prognosis in patients with liver cirrhosis and esophageal variceal bleeding.
Benedeto-Stojanov D; Nagorni A; Bjelaković G; Stojanov D; Mladenović B; Djenić N
Vojnosanit Pregl; 2009 Sep; 66(9):724-8. PubMed ID: 19877551
[TBL] [Abstract][Full Text] [Related]
11. Albumin-Bilirubin (ALBI) as an accurate and simple prognostic score for chronic hepatitis B-related liver cirrhosis.
Wang J; Zhang Z; Yan X; Li M; Xia J; Liu Y; Chen Y; Jia B; Zhu L; Zhu C; Huang R; Wu C
Dig Liver Dis; 2019 Aug; 51(8):1172-1178. PubMed ID: 30765220
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of zinc acetate hydrate for hypozincemia in the elderly is influenced by the initial accumulated exposure dose after taking zinc acetate hydrate.
So M; Tsuji Y; Suzuki T
Pharmazie; 2023 Oct; 78(9):201-206. PubMed ID: 38037215
[TBL] [Abstract][Full Text] [Related]
13. Time-course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis.
Atsukawa M; Tsubota A; Kondo C; Toyoda H; Nakamuta M; Takaguchi K; Watanabe T; Hiraoka A; Uojima H; Ishikawa T; Iwasa M; Tada T; Nozaki A; Chuma M; Fukunishi S; Asano T; Ogawa C; Abe H; Kato K; Hotta N; Shima T; Matsuura K; Mikami S; Tachi Y; Fujioka S; Okubo H; Shimada N; Tani J; Morishita A; Hidaka I; Moriya A; Tsuji K; Akahane T; Okubo T; Arai T; Kitamura M; Morita K; Kawata K; Tanaka Y; Kumada T; Iwakiri K;
Hepatol Res; 2022 Mar; 52(3):235-246. PubMed ID: 34861090
[TBL] [Abstract][Full Text] [Related]
14. Adrenal insufficiency in decompensated cirrhotic patients without infection: prevalence, predictors and impact on mortality.
Nandish HK; Arun CS; Nair HR; Gopalakrishna R; Kumar H; Venu RP
J R Coll Physicians Edinb; 2019 Dec; 49(4):277-281. PubMed ID: 31808452
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of risk factors for decompensated cirrhosis complicated with sepsis].
Ren HQ; Zhong S; Lei Y; Zhou Z
Zhonghua Gan Zang Bing Za Zhi; 2022 Nov; 30(11):1163-1169. PubMed ID: 36891692
[No Abstract] [Full Text] [Related]
16. Efficacy and Safety of Ledispavir/Sofosbuvir with or without Ribavirin in patients with Decompensated Liver Cirrhosis and Hepatitis C Infection: a Cohort Study.
Gheorghe LS; Preda C; Iliescu L; Istratescu D; Chifulescu AE; Pop CS; Trifan A; Stanciu C; Diculescu M; Voiosu T; Baicus C; Tugui L; Iacob S; Tieranu C; Meianu C; Manuc M
J Gastrointestin Liver Dis; 2020 Sep; 29(3):385-390. PubMed ID: 32919421
[TBL] [Abstract][Full Text] [Related]
17. Serum Zinc Level Classification System: Usefulness in Patients with Liver Cirrhosis.
Nishikawa H; Enomoto H; Yoh K; Iwata Y; Sakai Y; Kishino K; Ikeda N; Takashima T; Aizawa N; Takata R; Hasegawa K; Ishii N; Yuri Y; Nishimura T; Iijima H; Nishiguchi S
J Clin Med; 2019 Nov; 8(12):. PubMed ID: 31766742
[TBL] [Abstract][Full Text] [Related]
18. Child-Turcotte-Pugh versus model for end stage liver disease score for predicting survival in hospitalized patients with decompensated cirrhosis.
Chaurasia RK; Pradhan B; Chaudhary S; Jha SM
J Nepal Health Res Counc; 2013 Jan; 11(23):9-16. PubMed ID: 23787518
[TBL] [Abstract][Full Text] [Related]
19. The model for end-stage liver disease (MELD) predicts early and late outcomes of cardiovascular operations in patients with liver cirrhosis.
Morimoto N; Okada K; Okita Y
Ann Thorac Surg; 2013 Nov; 96(5):1672-8. PubMed ID: 23987897
[TBL] [Abstract][Full Text] [Related]
20. Assessment of prognostic performance of Albumin-Bilirubin, Child-Pugh, and Model for End-stage Liver Disease scores in patients with liver cirrhosis complicated with acute upper gastrointestinal bleeding.
Xavier SA; Vilas-Boas R; Boal Carvalho P; Magalhães JT; Marinho CM; Cotter JB
Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):652-658. PubMed ID: 29438135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
